كينيا - الإنجليزية - Pharmacy and Poisons Board

sun pharmaceutical industries limited acme plaza andheri kurla road andheri(e) mumbai- - bimatoprost - eye drops - 03 mg per ml - ophthalmological antiglaucoma preparations and

كينيا - الإنجليزية - Pharmacy and Poisons Board

allergan pharmaceuticals (pty) ltd 30 new road (entrance off bavaria road), - bimatoprost - eye drops - 0.3 mg/ml bimatoprost - ophthalmological antiglaucoma preparations and

كندا - الإنجليزية - Health Canada

sandoz canada incorporated - bimatoprost - solution - 0.03% - bimatoprost 0.03% - prostaglandin analogs

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

lupin limited - bimatoprost (unii: qxs94885mz) (bimatoprost - unii:qxs94885mz) - bimatoprost 0.3 mg in 1 ml - bimatoprost ophthalmic solution, 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. none teratogenic effects:   in embryo/fetal developmental studies in pregnant mice and rats, abortion was observed at oral doses of bimatoprost which achieved at least 33 or 97 times, respectively, the maximum intended human exposure based on blood auc levels. at doses at least 41 times the maximum intended human exposure based on blood auc levels, the gestation length was reduced in the dams, the incidence of dead fetuses, late resorptions, peri- and postnatal pup mortality was increased, and pup body weights were reduced. there are no adequate and well-controlled studies of bimatoprost ophthalmic solution, 0.03% administration in pregnant women. because animal reproductive studies are not always predictive of human response. bimatoprost ophthalmic solution, 0.03% should be administered during pregnancy only if the potential benefit justifies the

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

lupin pharmaceuticals, inc. - bimatoprost (unii: qxs94885mz) (bimatoprost - unii:qxs94885mz) - bimatoprost 0.3 mg in 1 ml - bimatoprost ophthalmic solution, 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension. bimatoprost ophthalmic solution, 0.03% is contraindicated in patients with hypersensitivity to bimatoprost or to any of the ingredients [see adverse reactions (6.2)] . risk summary there are no adequate and well-controlled studies of bimatoprost ophthalmic solution, 0.03% administration in pregnant women. there is no increase in the risk of major birth defects or miscarriages based on bimatoprost postmarketing experience. in embryofetal developmental studies, administration of bimatoprost in pregnant mice and rats during organogensis, resulted in abortion and early delivery at oral doses at least 33 times (mice) or 94 times (rats) the human exposure at the recommended clinical dose (based on blood area under the curve [auc] levels). these adverse effects were not observed at 2.6 times (mice) and 47 times (rats) the human exposure at the recommended

المملكة العربية السعودية - الإنجليزية - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

allergan pharmaceuticals ltd, ireland - timolol maleate,bimatoprost - eye drops, solution - 5,0.3 mg/ml,

المملكة العربية السعودية - الإنجليزية - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

allergan pharmaceuticals ltd, ireland - timolol maleate,bimatoprost - eye drops, solution - 5,0.3 mg/ml,

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - bimatoprost 0.3 mg/ml - eye drops, solution - 0.3 mg/ml - active: bimatoprost 0.3 mg/ml excipient: citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid sodium chloride sodium hydroxide water for injection - indicated as monotherapy for the reduction of elevated intraocular pressure (iop) in patients with chronic glaucoma or ocular hypertension; or as adjunctive therapy in patients not adequately controlled on other agents.

المملكة العربية السعودية - الإنجليزية - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

abbvie deutschland gmbh, germany - timolol maleate,bimatoprost - eye drops, solution - 5,0.3 mg/ml,

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

abbvie pte. ltd. - bimatoprost; timolol maleate 6.8 mg/ml eqv timolol - solution, sterile - bimatoprost 0.3 mg/ml; timolol maleate 6.8 mg/ml eqv timolol 5 mg/ml